Recent real|world treatment patterns and outcomes in US ...

Recent real-world treatment patterns and outcomes in US ... - PubMed

Abstract. Background: In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1-3 therapy lines, newer agents ...

Recent real-world treatment patterns and outcomes in US patients ...

Median rwPFS (95% confidence interval [CI]) declined from 12.0 months (10.9, 13.4) at first-line to 2.9 months (2.3, 4.0) at fourth-line. Median ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

Flatiron patient selection. Data were derived from the Flatiron Health deidentified US electronic health records database between January 2016 ...

Recent real-world treatment patterns and outcomes in US patients ...

Median real-world progression-free survival (rwPFS) was 12.0 to 3.5 months (first- to fifth-line), and median real-world overall survival (rwOS) ...

Real-world treatment patterns and outcomes in patients with HR+ ...

Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States.

Real-World Treatment Patterns and Outcomes by Line of Therapy ...

Willamette Valley Cancer Institute & Research Center/US Oncology Research, Eugene, OR, USA. 3 Lymphoma Research Foundation, New York City, NY, USA. 4 Janssen, ...

Real-World Treatment Patterns and Clinical Outcomes After ...

PURPOSETo characterize treatment patterns and real-world clinical outcomes of patients with metastatic non–small cell lung cancer (mNSCLC) ...

US real-world first-line (1L) treatment patterns and outcomes for ...

More recently, avelumab, received approval as the first ICI for the maintenance treatment of patients who have not progressed on 1L platinum- ...

Treatment Patterns and Outcomes in Patients with Relapsed ...

Therefore, we evaluated the real-world (RW) variations in Tx patterns and clinical outcomes in a US population of pts with RRMM receiving ≥3 ...

Current Real-World Treatment Patterns and Outcomes in Patients ...

This study assessed treatment patterns and outcomes of patients with RRMM receiving ≥2 lines of therapy in US community oncology practices.

Treatment patterns and outcomes according to cytogenetic risk ...

Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma. Expert Rev Hematol. 2020;13:1017–25.

Front‐line treatment patterns in multiple myeloma: An analysis of ...

... current real-world treatment practices and outcomes in this rapidly evolving environment. For example, the real-world use of front ...

Real-world treatment patterns and outcomes for patients with ...

Multiple myeloma (MM) is the second most common haematological malignancy [1], [2]. Patient survival has improved significantly in recent decades [2], related ...

Real-world treatment patterns and outcomes for patients with ...

Nordic patient registry data provide real-world evidence on treatments and outcomes. •. Over 11,000 patients treated for multiple myeloma (2010– ...

Frontline treatment patterns and attrition rates by subsequent lines of ...

... treatment patterns and patient outcomes in a real-world setting. Available real-world data suggest that most patients diagnosed with MM ...

Recent treatment patterns and real-world survival following first-line ...

These findings support the need for new treatment strategies and innovative treatments to improve clinical outcomes for patients with ES-SCLC.

Real-world treatment patterns in relapsed/refractory multiple myeloma

We evaluated clinical outcomes among RRMM patients in the 1-year following treatment ... Mean (SD) time to a new treatment was 4.7 (5.3) months and median OS was ...

Real-World Analysis of Treatment Patterns and Outcomes in ...

Although there are recent advances in the multiple myeloma (MM) therapeutic landscape, 5-year overall survival (OS) in patients with translocation of ...

Real-world treatment patterns and clinical outcomes for inpatients ...

Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021. Olulade Ayodele ...

Real-world treatment patterns in relapsed/refractory multiple myeloma

... recent decade: results from a Swedish population-based study. ... Novel treatment (Tx) use and associated outcomes among African American ...